← Back to Search

Non-ablative Laser Therapy for Facial Photoaging

Phase 4

Waitlist Available

Led By Edward Lain, MD, MBA

Research Sponsored by Austin Institute for Clinical Research

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline to day 98

Awards & highlights

Study Summary

This trial studies how a placebo moisturizer & non-ablative laser can improve the signs of photoaging. Physician assessments, patient reports & photos will be used.

Who is the study for?

This trial is for healthy adult females aged 25-70 with all skin types, who have symmetrical signs of aging on their face. They must not be pregnant or nursing, and agree to use contraception. Excluded are those with facial cancer history, certain medical conditions, severe sunburn or tan, tattoos/scars in test areas, using specific medications including anti-inflammatories and immunosuppressives.Check my eligibility

What is being tested?

The study tests the effectiveness of a placebo moisturizer combined with non-ablative laser treatments (LaseMD Laser and Sciton Laser) against signs of photoaging like discoloration and texture changes. Participants' results will be assessed through physician evaluations, self-reports, and digital photos.See study design

What are the potential side effects?

While the trial does not explicitly list side effects for this phase 4 study, typical side effects from non-ablative lasers may include redness, swelling at the treatment site(s), mild discomfort during treatment; rare cases might involve blistering or changes in skin pigmentation.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline to day 98

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline to day 98

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to day 98 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in facial dyschromia

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Phyto A+ Brightening TreatmentActive Control3 Interventions

Phyto A+ Brightening Treatment is a serum comprised of a soothing botanical blend matched with a keratolytic (3% azeleic acid), 2.5% niacinamide, a brightening compound (2 % α-arbutin), and botanical extracts. Product will be topically applied to the assigned side of the face, either left or right side, at Day 0, Day 14, Day 28, Day 42, Day 70, and Day 98.

Group II: Placebo MoisturizerPlacebo Group3 Interventions

Placebo Moisturizer will be topically applied to the assigned side of the face, either left or right side, at Day 0, Day 14, Day 28, Day 42, Day 70, and Day 98.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

SkinCeuticalsUNKNOWN

3 Previous Clinical Trials

59 Total Patients Enrolled

Austin Institute for Clinical ResearchLead Sponsor

5 Previous Clinical Trials

115 Total Patients Enrolled

Edward Lain, MD, MBAPrincipal InvestigatorAustin Institute for Clinical Research

6 Previous Clinical Trials

146 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the Phyto A+ Brightening Treatment been sanctioned by the Federal Drug Administration?

"Data from the Phase 4 trial suggests that Phyto A+ Brightening Treatment is safe, thus receiving a score of 3."

Answered by AI

Is this study accessible to participants over the age of 45?

"In order to be eligible, the participant must fit within the age parameters of 25 and 70 years old."

Answered by AI

Are there any specific qualifications for individuals to become a participant in this research?

"Individuals between 25 and 70 years old with solar elastosis may be eligible to join this clinical investigation. 40 patients will take part in the trial overall."

Answered by AI

Is recruitment actively occurring for this clinical experiment?

"As stated on clinicaltrials.gov, this particular trial has already reached its recruitment goals and is no longer accepting participants. The study was initially posted in December 2021 and last edited in October 2023. Notwithstanding, 57 other trials are currently searching for patients to join their respective studies."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Trial Evaluating Both Tolerability and Improvement for Signs of Facial Photoaging, Discoloration, and Texture in Adult Females of All Skin Types by Combining a Placebo Moisturizer and Non-ablative Laser.

2023. "Trial Evaluating Both Tolerability and Improvement for Signs of Facial Photoaging, Discoloration, and Texture in Adult Females of All Skin Types by Combining a Placebo Moisturizer and Non-ablative Laser.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06090071.